FX Receives 510(k) Clearance for FX V135 Shoulder Arthroplasty Platform

FX received FDA 510(k) clearance for its new FX V135 platform, which includes a new-to-market mini stem humeral component that is set at 135° for both the anatomical and reverse configurations. With FX’s net shape molded humeral cups, the reverse construct also allows surgeons the option to use an asymmetric humeral cup to change the inclination to 145° through the humeral cup component.

FX received FDA 510(k) clearance for its FX V135 Shoulder Replacement Platform. Photo courtesy of FX.

The FX V135 anatomical configuration features a taper component that will allow for 360° of eccentricity, providing for a dual eccentricity offering between the taper and the humeral head components. New with this system, FX is launching humeral head components with variable head heights to allow surgeons more flexibility to best match the patients’ anatomy.

The FX V135 is a 70mm humeral stem that is proximally coated with hydroxyapatite and features suture holes proximally for soft tissue repair, net shape molded humeral cups, Titanium Nitride coated and uncoated Cobalt Chrome humeral heads and glenospheres, as well as 12 different baseplate options in the reverse construct. The humeral stem inclination is at 135° for the anatomical construct and 135° or 145° for the reverse construct.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE